NCT06506786

Brief Summary

The purpose of this research is to explore what types of microbes are present on garden-fresh versus store-bought fruits and vegetables, as well as how they might affect the human gut microbiome.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 17, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

July 17, 2024

Status Verified

July 1, 2024

Enrollment Period

1.5 years

First QC Date

May 24, 2024

Last Update Submit

July 16, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Difference in fecal bacterial abundance, as characterized by qPCR with "universal" bacterial primers

    ANOVA statistical test of bacterial gene copies (a proxy for absolute abundance) used to compare whether Garden-Fresh Produce and Supermarket Produce interventions differentially affect fecal bacterial abundance.

    Baseline, 1 week, 3 weeks

  • Difference in fecal microbial diversity, as characterized by shotgun metagenomics.

    ANOVA statistical test of Shannon index used to compare whether Garden-Fresh Produce and Supermarket Produce interventions differentially affect fecal microbial diversity.

    Baseline, 1 week, 3 weeks

  • Difference in fecal microbial composition, as characterized by shotgun metagenomics.

    PERMANOVA statistical test used to compare whether Garden-Fresh Produce and Supermarket Produce interventions differentially affect fecal microbial composition.

    Baseline, 1 week, 3 weeks

  • Presence of differentially abundant microbial taxa, as characterized by shotgun metagenomics.

    Negative binomial GLM statistical test used to identify microbial taxa associated with either Garden-Fresh Produce or Supermarket Produce intervention.

    Baseline, 1 week, 3 weeks

Study Arms (2)

Garden First

EXPERIMENTAL

Participants assigned to this study arm undergo the Garden-fresh Produce intervention during the first period and the Supermarket Produce intervention during the second period.

Other: Garden-fresh ProduceOther: Supermarket Produce

Supermarket First

EXPERIMENTAL

Participants assigned to this study arm undergo the Supermarket Produce intervention during the first period and the Garden-fresh Produce intervention during the second period.

Other: Garden-fresh ProduceOther: Supermarket Produce

Interventions

Participants are asked to consume the USDA-recommended amounts of fruits and vegetables harvested from their gardens.

Garden FirstSupermarket First

Participants are asked to consume the USDA-recommended amounts of fruits and vegetables purchased from a supermarket.

Garden FirstSupermarket First

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may not qualify if:

  • Body mass index (BMI) greater than or equal to 35 or less than or equal to 18.
  • Age under 18 or over 45.
  • Female who is pregnant or lactating.
  • Irregular bowel movements and/or stool consistency.
  • Plans to travel, move residences, or other major life change during the study period (August-October 2023).
  • Unable to speak, read, and write English.
  • Use of any of the following drugs within the last 6 months:
  • systemic antibiotics, antifungals, antivirals or antiparasitics (intravenous, intramuscular, or oral);
  • oral, intravenous, intramuscular, nasal or inhaled corticosteroids;
  • cytokines;
  • methotrexate or immunosuppressive cytotoxic agents;
  • large doses of commercial probiotics consumed (greater than or equal to 108 cfu or organisms per day) - includes tablets, capsules, lozenges, chewing gum or powders in which probiotic is a primary component. Ordinary dietary components such as fermented beverages/milks, yogurts, foods do not apply.
  • Acute disease at the time of enrollment (defer sampling until subject recovers). Acute disease is defined as the presence of a moderate or severe illness with or without fever.
  • History of cancer except for squamous or basal cell carcinomas of the skin that have been medically managed by local excision.
  • Unstable dietary history as defined by major changes in diet during the previous month, where the subject has eliminated or significantly increased a major food group in the diet.
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for Health in the Built Environment, University of Oregon

Eugene, Oregon, 97403, United States

RECRUITING

Study Officials

  • Gwynne Mhuireach, PhD

    University of Oregon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gwynne Mhuireach, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2024

First Posted

July 17, 2024

Study Start

July 1, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

July 17, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations